OMERS

Ellevio announces a cash offer of SEK 90 per share to the shareholders of Dala Energi

Retrieved on: 
Tuesday, April 2, 2024
Energi, OMERS, Electricity, Employment, Baltic, Communication, Knowledge, FDI, History, Acquisition, Transport, Wind, City, Investment, Stockholm District Court, AMF, Weather, Legislation, Telecommunications, Companies Act, Nasdaq Stockholm, ICT, Cryptocurrency

STOCKHOLM, April 2, 2024 /PRNewswire/ -- The Ellevio group, through Ellevio Holding 1 AB[1] ("Ellevio") together with its subsidiaries (the "Ellevio Group"), hereby announces a public offer to the shareholders of Dala Energi AB (publ)[2] ("Dala Energi" or the "Company") to tender all shares in Dala Energi to Ellevio at a price of SEK 90 per share (the "Offer"), which represents a premium of 86.5 per cent to the volume-weighted average trading price of SEK 48.3 for the shares over the last 90 trading days. The shares in Dala Energi are listed on Nasdaq First North Growth Market.

Key Points: 
  • Ellevio offers SEK 90 in cash per share (the "Offer Price") in Dala Energi.
  • The total value of the Offer, based on all 24,771,656 shares in Dala Energi amounts to approximately SEK 2,229 million.
  • Ellevio offers SEK 90 in cash for each share in Dala Energi.
  • Dala Energi is the parent company in a group with the fully owned subsidiaries Dala Energi Kraftproduktion AB, Dala Energi Fibernät AB and Dala Energi Elnät AB.

Ellevio announces a cash offer of SEK 90 per share to the shareholders of Dala Energi

Retrieved on: 
Tuesday, April 2, 2024
Energi, OMERS, Electricity, Employment, Baltic, Communication, Knowledge, FDI, History, Acquisition, Transport, Wind, City, Investment, Stockholm District Court, AMF, Weather, Legislation, Telecommunications, Companies Act, Nasdaq Stockholm, ICT, Cryptocurrency

STOCKHOLM , April 2, 2024 /PRNewswire/ -- The Ellevio group, through Ellevio Holding 1 AB[1] ("Ellevio") together with its subsidiaries (the "Ellevio Group"), hereby announces a public offer to the shareholders of Dala Energi AB (publ)[2] ("Dala Energi" or the "Company") to tender all shares in Dala Energi to Ellevio at a price of SEK 90 per share (the "Offer"), which represents a premium of 86.5 per cent to the volume-weighted average trading price of SEK 48.3 for the shares over the last 90 trading days. The shares in Dala Energi are listed on Nasdaq First North Growth Market.

Key Points: 
  • Ellevio offers SEK 90 in cash per share (the "Offer Price") in Dala Energi.
  • The total value of the Offer, based on all 24,771,656 shares in Dala Energi amounts to approximately SEK 2,229 million.
  • Ellevio offers SEK 90 in cash for each share in Dala Energi.
  • Dala Energi is the parent company in a group with the fully owned subsidiaries Dala Energi Kraftproduktion AB, Dala Energi Fibernät AB and Dala Energi Elnät AB.

Specsavers and Municipal Retirees Organization Ontario Partner to Make Eye Health More Affordable for over 36,000 Members

Retrieved on: 
Tuesday, March 26, 2024
OMERS, Partnership, OCT, Optometry, Patient, Eye, 3D, Contact, Specsavers, Lens

TORONTO, March 26, 2024 /CNW/ - Specsavers, a leading eyecare and eyewear provider, has announced a partnership with the Municipal Retirees Organization Ontario (MROO), the largest organization supporting OMERS pensioners.

Key Points: 
  • TORONTO, March 26, 2024 /CNW/ - Specsavers, a leading eyecare and eyewear provider, has announced a partnership with the Municipal Retirees Organization Ontario (MROO), the largest organization supporting OMERS pensioners.
  • Beginning today, MROO members can visit one of the over 50 Specsavers locations in Ontario to save when it comes to maintaining their eye health.
  • "We're delighted to partner with MROO and bring our passion for making quality eyecare and eyewear affordable and accessible to all their members," said Bill Moir, Managing Director of Specsavers Canada.
  • "The focus on eye health and great value makes Specsavers a perfect partner for MROO," said Keith Robicheau, President of MROO.

Beanfield welcomes new SVP, Commercial Services, Chris Adamkowski

Retrieved on: 
Thursday, March 7, 2024
Cloud, Google Cloud, Angel investor, Entrepreneurship, DEI, AI, SVP, Growth, MBA, Queen's University, Fintech, University, OMERS, Management

Chris Adamkowski comes to Beanfield with a wealth of scaling experience, including more than a decade in senior leadership roles at Google and Google Cloud.

Key Points: 
  • Chris Adamkowski comes to Beanfield with a wealth of scaling experience, including more than a decade in senior leadership roles at Google and Google Cloud.
  • With an MBA from Queen's University, Mr. Adamkowski is passionate about entrepreneurship, DEI, and helping Canadian businesses grow.
  • Dan Armstrong, CEO and Founder of Beanfield, said, “We are thrilled to have Chris join the Beanfield team.
  • “I am thrilled to be joining Beanfield and contributing to the mission of connecting communities through Canada's largest privately owned fibre-optic network.

OMERS Generates $5.6 billion in Investment Income in 2023

Retrieved on: 
Friday, February 23, 2024
Pension, Bruce Power, Plan, Retirement, OMERS, Yorkdale Shopping Centre, Investment

TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- OMERS, the defined benefit pension plan for broader municipal sector employees in the province of Ontario, generated a 2023 investment return of 4.6%, or $5.6 billion, net of expenses.

Key Points: 
  • TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- OMERS, the defined benefit pension plan for broader municipal sector employees in the province of Ontario, generated a 2023 investment return of 4.6%, or $5.6 billion, net of expenses.
  • Over the past 10 years, OMERS has averaged an annual investment return of 7.3%, net of expenses, adding $66.4 billion to the Plan.
  • Net assets at December 31, 2023, were $128.6 billion, up from $124.2 billion in 2022, and the Plan reported a smoothed funded status of 97%, up from 95% last year.
  • “Public equities and fixed income had a strong year and fixed income assets benefitted from higher interest rates.

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET

Retrieved on: 
Wednesday, February 7, 2024
COVID-19, Research, Infectious Diseases, Clinical Trials, Biotechnology, Health, Pharmaceutical, Other Science, Science, B cell, Chronic obstructive pulmonary disease, Pharmacokinetics, KIT, HCV, Patient, Safety, Heart, Drug discovery, Virology, Fiscal, Disease, CSU, ADME, RSV, Sale, OMERS, Viral load, Medication, Asthma, Conference, Pharmaceutical industry

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs in virology and immunology, today reported financial results for its fiscal first quarter ended December 31, 2023.

Key Points: 
  • Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs in virology and immunology, today reported financial results for its fiscal first quarter ended December 31, 2023.
  • “In 2024, Enanta began a year which will be marked by execution and value creation across the company.
  • For the three months ended December 31, 2022, total revenue was $23.6 million and was primarily related to royalties on AbbVie’s sales of MAVYRET®/MAVIRET®.
  • Interest expense from the royalty sale was $3.4 million for the three months ended December 31, 2023.

Beanfield proudly welcomes new SVP, Residential, Michael Massie

Retrieved on: 
Thursday, January 18, 2024
Growth, OMERS, Bell, Cincinnati Bell, GTA, SVP, Construction

Michael Massie, having spent the last year in Hawaii, has relocated back to the GTA where he’s spent the majority of his life.

Key Points: 
  • Michael Massie, having spent the last year in Hawaii, has relocated back to the GTA where he’s spent the majority of his life.
  • He comes to Beanfield with a wealth of telecom experience, most recently leading Cincinnati Bell and Hawaii Telecom’s National Residential MDU Strategy.
  • Dan Armstrong, CEO and Founder of Beanfield, said, “We are thrilled to have Mike join the Beanfield team.
  • Beanfield has plans to continue their expansion in key markets, with emphasis on residential growth in Toronto, Vancouver and Ottawa.

Stella-Jones Announces Appointment to Board of Directors

Retrieved on: 
Thursday, January 11, 2024
OMERS, Corporation, Certification, Empire Company, Human resources, SJ, TSX, Cornell University, HR, TMX Group, Chairperson, Management

MONTREAL, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced the appointment of Ms. Michelle Banik to its Board of Directors.

Key Points: 
  • MONTREAL, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced the appointment of Ms. Michelle Banik to its Board of Directors.
  • Ms. Banik is an accomplished Human Resources (“HR”) professional and brings particular expertise in performance management, talent optimization, HR innovation, succession planning and executive compensation to the Stella-Jones Board.
  • “We are delighted to welcome Michelle to the Stella-Jones Board of Directors”, said Katherine Lehman, Chair of the Board.
  • Ms. Banik’s appointment is effective January 15, 2024, and brings the total number of Board members to eleven.

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET

Retrieved on: 
Monday, November 20, 2023
Health, Infectious Diseases, COVID-19, Clinical Trials, Research, Science, Pharmaceutical, Sale, Heart, Southampton General Hospital, Pediatrics, Patient, Conference, Doctor of Philosophy, Viral, Webcast, Safety, RSV, Human, Respiratory system, MBBS, Federal, Chronic obstructive pulmonary disease, Texas A&M University, O'Driscoll (surname), Dean (education), Respiratory Medicine, Pharmacokinetics, University, FRCP, Fast Track, Asthma, Medication, Infection, FERS, Urinary tract infection, Virology, Ageing, Upper respiratory tract infection, Viral load, Clinical trial, Tax, HBV, FDA, Vaccine, Faculty, OMERS, HCV, State Administrative Expenses, Pharmaceutical industry, Life insurance, Cryptocurrency, Pfizer, Cantab, FIDSA, FAAP, Medicine, MD

(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections, today reported financial results for its fiscal fourth quarter and year ended September 30, 2023.

Key Points: 
  • (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections, today reported financial results for its fiscal fourth quarter and year ended September 30, 2023.
  • For the twelve months ended September 30, 2023, total revenue was $79.2 million compared to $86.2 million for the same period in 2022.
  • The decrease in the quarter and in year-over-year revenue is due to a decline in AbbVie’s sales of MAVYRET®/MAVIRET®.
  • Non-cash interest expense was $3.2 million for the three months ended September 30, 2023 and $5.1 million for the twelve months ended September 30, 2023.

Brandon Weening joins Lime Connect Canada Board of Directors

Retrieved on: 
Monday, December 4, 2023
Executive sponsor, Corporation, Acquisition, Organization, Disability, Culture, Rogers Communications, Partnership, Lime, OMERS, Oxford Properties, Management, Nursing

NEW YORK and TORONTO, Dec. 4, 2023 /PRNewswire-PRWeb/ -- Lime Connect (Lime) is pleased to announce that Brandon Weening, Executive Vice President, Corporate and Capital Markets Finance at OMERS, has joined the not-for-profit organization as a member of its Canada Board of Directors. Weening's position highlights OMERS and Oxford Properties (OMERS) deep commitment to supporting people with disabilities.

Key Points: 
  • NEW YORK and TORONTO, Dec. 4, 2023 /PRNewswire-PRWeb/ -- Lime Connect (Lime) is pleased to announce that Brandon Weening, Executive Vice President, Corporate and Capital Markets Finance at OMERS, has joined the not-for-profit organization as a member of its Canada Board of Directors.
  • I'm proud to join Lime Connect Canada, and to support its mission — breaking stereotypes and leading employers to empower professionals with disabilities.
  • Andrew Masson, Senior Director of Corporate HR at Rogers Communications, and president of Lime Connect Canada's Board of Directors, says, "Brandon is a highly respected business professional, and his leadership and strategic focus are assets to Lime Connect Canada's work throughout the provinces.
  • This is why I'm proud to join Lime Connect Canada, and to support its mission — breaking stereotypes and leading employers to empower professionals with disabilities."